4 documents found, page 1 of 1
Global change, climate change, and asthma in children: Direct and indirect effe...
Le Souëf, PN; Adachi, Y; Anastasiou, E; Ansotegui, IJ; Badellino, HA; Banzon, T; Beltrán, CP; D'Amato, G; El-Sayed, ZA; Gómez, RM; Hossny, E; Kalayci, ÖThe twenty-first century has seen a fundamental shift in disease epidemiology with anthropogenic environmental change emerging as the likely dominant factor affecting the distribution and severity of current and future human disease. This is especially true of allergic diseases and asthma with their intimate relationship with the natural environment. Climate change-related variables including increased ambient ...
Global change, climate change, and asthma in children: Direct and indirect effe...
Le Souëf, PN; Adachi, Y; Anastasiou, E; Ansotegui, IJ; Badellino, HA; Banzon, T; Beltrán, CP; D'Amato, G; El-Sayed, ZA; Gómez, RM; Hossny, E; Kalayci, ÖThe twenty-first century has seen a fundamental shift in disease epidemiology with anthropogenic environmental change emerging as the likely dominant factor affecting the distribution and severity of current and future human disease. This is especially true of allergic diseases and asthma with their intimate relationship with the natural environment. Climate change-related variables including increased ambient ...
Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden
Papadopoulos, NG; Custovic, A; Deschildre, A; Mathioudakis, AG; Phipatanakul, W; Wong, G; Xepapadaki, P; Agache, I; Bacharier, L; Bonini, MIt is unclear whether asthma may affect susceptibility or severity of coronavirus disease 2019 (COVID-19) in children and how pediatric asthma services worldwide have responded to the pandemic.
X-Linked Agammaglobulinemia (XLA):Phenotype, Diagnosis, and Therapeutic Challen...
El-Sayed, ZA; Abramova, I; Aldave, JC; Al-Herz, W; Bezrodnik, L; Boukari, R; Bousfiha, AA; Cancrini, C; Condino-Neto, A; Dbaibo, G; Derfalvi, BX-linked agammaglobulinemia is an inherited immunodeficiency recognized since 1952. In spite of seven decades of experience, there is still a limited understanding of regional differences in presentation and complications. This study was designed by the Primary Immunodeficiencies Committee of the World Allergy Organization to better understand regional needs, challenges and unique patient features.